[Antitumor properties of mixed coordination compounds of copper (II) and alpha-amino acids].
D000230:Adenocarcinoma / Q000188:drug therapy; D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents; D003300:Copper / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D007414:Intestinal Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008558:Melphalan / Q000008:administration & dosage; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012417:Rumen; D012511:Sarcoma 37 / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000596:Amino Acids; D000970:Antineoplastic Agents; D003300:Copper; D008558:Melphalan
Protivoopukholevye svoĭstva smeshannykh koordinatsionnykh soedineniĭ medi (II) s alpha-aminokislotami.